Improving Disease Management through Innovative Microbiology Solutions

DeepChek®
Genotyping through NGS & Sanger Sequencing
  • HIV
  • SARS CoV-2
  • HCV
  • TB
  • 16S RNA
More information

ABL Diagnostics Announces UltraGene Respiratory Pathogens 21 After CE-IVD Registration by ABL SA Luxembourg

https://www.einpresswire.com/article/929034320/abl-diagnostics-announces-ultragene-respiratory-pathogens-21-after-ce-ivd-registration-by-abl-sa-luxembourg

Read More

ABL Diagnostics Selected by the Évry Commercial Court to Acquire TEXCELL’s Operations

https://www.einpresswire.com/article/928571332/abl-diagnostics-selected-by-the-vry-commercial-court-to-acquire-texcell-s-operations

Read More

DeepChek® & HybridChek TB Assays & SoftwareComplete Coverage for Tuberculosis Drug Resistance Testing  by Amplicon & Hybrid Capture NGS Sequencing.

https://mailchi.mp/abldiagnostics/tb2026?e=e8da2024cf

Read More

ABL Diagnostics Confirms BSI Partnership for IVDR Transition and Long-Term Availability of its CE-IVD Medical Devices

https://www.einpresswire.com/article/927085611/abl-diagnostics-confirms-bsi-partnership-for-ivdr-transition-and-long-term-availability-of-its-ce-ivd-medical-devices

Read More

Subscribe to our newsletter

Scroll to Top